Liver Fibroses: Clinical Trials

33 trials for Liver Fibroses, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

18 completed, 4 recruiting, 4 unknown, 3 terminated. 11 Not applicable, 3 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable11Completed 6, Terminated 3, Active not recruiting 1, Unknown 1
Phase 23Completed 1, Not yet recruiting 1, Recruiting 1
Phase 31Recruiting 1

Follow Liver Fibroses: new trials by email Literature Review of Liver Fibroses trials Research Report on Liver Fibroses

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Zinc Sulphate in Treatment Fibrosis in HBV Patient Receiving Antiviral Therapy
Entecavir (ETV), Zinc (zinc sulphate) - Liver Fibroses, HBV (Hepatitis B Virus)
Phase 2Not yet recruitingTanta University442025-09-012025-08-28
Safety and Efficacy of Atorvastatin v. Placebo on HCC Risk
Atorvastatin 20mg, Placebo - Liver Fibroses, Cirrhosis
Phase 2RecruitingRaymond Chung602023-05-102026-10-07
A Physiologic Analysis of Endoscopic Sleeve Gastroplasty (ESG)
Insulin Resistance, Quality of Life Assessment, Liver Function Test - Non-alcoholic Steatohepatitis (NASH), Endoscopic Sleeve Gastroplasty
Not applicableActive not recruitingBrigham and Women's Hospital202021-05-062025-12-02
Clinical Performance of LIVERFASt Test Compared w/ Liver Biopsy in Patients w/ NAFLD.
LIVERFASt - Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis
Not applicableCompletedFibronostics USA, Inc2412021-01-072022-08-02
Liquid Biopsy for NASH and Liver Fibrosis
Liver Biopsy - NASH - Nonalcoholic Steatohepatitis, Liver Fibroses
CompletedCatholic University of the Sacred Heart1502020-12-162021-05-19
Integrated Diagnostics for Early Diagnosis of Liver Disease
Blood tests for Single Nucleotide Polymorphisms, Faecal microbiome analysis, Serum for diagnostic biomarkers - Non-Alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis
RecruitingManchester University NHS Foundation Trust12002020-10-212026-02-09
The Sonic Incytes Liver Incytes System, Evaluation of Liver Fibrosis and Steatosis Versus MRE and MRI PDFF
Liver Incytes System - Non-Alcoholic Fatty Liver Disease (NAFLD), Non-Alcoholic Steatohepatitis (NASH)
Not applicableCompletedSonic Incytes1642020-10-212026-07-20
The EUS ShearWave Elastography Liver Fibrosis Study
ShearWave Elastography (SWE) in Endoscopic Ultrasound (EUS), FibroScan, ALOKA ARIETTA 850 - - Liver Fibroses
CompletedOlympus Corporation of the Americas522020-07-142021-09-09
EUS Elastography for Predicting Cirrhotic-related Complications
EUS elastography - Liver Fibroses
Active not recruitingChinese University of Hong Kong502019-11-042026-03-19
Comparative and Additive Diagnostic Performance of Magnetic Resonance Elastography (MRE) and Corrected-T1 (cT1) for Fibrosis and Inflammation in Nonalcoholic Steatohepatitis (NASH) Using Histology As Reference
Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis
CompletedUniversity of California, San Diego302019-05-212024-11-25
Evaluation of the Effect of IHHT on Vascular Stiffness and Elasticity of the Liver Tissue in Patients With MS.
Interval hypoxic-hyperoxic training (IHHT) using respiratory therapy unit ReOxy., Simulating Interval hypoxic-hyperoxic training (IHHT) using respiratory therapy unit ReOxy. - Vascular Stiffness, Liver Fibroses
Not applicableCompletedI.M. Sechenov First Moscow State Medical University622019-04-102021-03-10
The Use of Novel Diagnostic Tools to Increase Detection of Early Fibrosis in Cystic Fibrosis Related Liver Disease to Improve Clinical Management
Cystic Fibrosis, Liver Fibroses
CompletedManchester University NHS Foundation Trust1572019-02-152024-05-01
Accuracy of Imaging Techniques in Diagnosing Steatohepatitis and Fibrosis in NAFLD Patients
Ultrasound and Magnetic Resonance - Non-Alcoholic Fatty Liver Disease, Steatohepatitis, Nonalcoholic
Not applicableCompletedAzienda USL Reggio Emilia - IRCCS282019-01-012026-07-24
Prevalence of Liver Fibrosis and Cirrhosis in Patients With Squamous Cell Carcinoma of the Head and Neck
Evaluation of the hepatic fibrosis - Liver Fibroses, Liver Cirrhoses
Not applicableTerminatedCentre Hospitalier Universitaire, Amiens22018-12-132026-06-25
Effect of Some Drugs on Liver Fibrosis
Candesartan, Ramipril - Liver Fibroses
Phase 3RecruitingSherief Abd-Elsalam452018-10-012018-12-10
Liver Fibrosis in Peri-menopausal Women
Nonalcoholic Steatohepatitis, Liver Fibroses
UnknownChang Gung Memorial Hospital2002018-08-012018-08-21
Competitive Accuracy of Radiological Imaging Compared to Liver Biopsy in Patients With Liver Fibrosis
Liver elastography (2D-SWE), Liver scintigraphy with 99mTc-mebrofenin - Liver Fibroses, Liver Cirrhosis
CompletedVilnius University722018-08-012021-08-17
Liver Steatosis and Stiffness in HIV
Fibroscan - HIV Infections, Fatty Liver
UnknownChang Gung Memorial Hospital2002018-08-012018-08-21
Liver, Pancreas and Thyroid Function in Burn Patients
Ultrasound/transient elastography - Burns, Liver Fibroses
WithdrawnThe University of Texas Medical Branch, Galveston2018-06-252023-06-18
Increased Liver Stiffness: A Study of Acoustic Radiation Force Impulse (ARFI) Elastography
Ultrasound with ARFI (acoustic radiation force impulse), Ultrasound with backscatter imaging - Liver Fibroses
CompletedUniversity of Michigan252018-04-112020-06-02

Showing 20 of 33. Sign in to see all of them.

Narrower conditions

Liver Cirrhosis (33)  ·  Non-alcoholic Fatty Liver Disease (12)  ·  Fatty Liver (5)  ·  Fibrosis (3)  ·  Liver Diseases (3)  ·  Diabetes Mellitus (2)  ·  Hepatitis (2)  ·  Metabolic Syndrome (2)  ·  Obesity (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Alcohol-Induced Disorders (1)  ·  Bone Diseases, Metabolic (1)  ·  Burns (1)  ·  Carcinoma, Hepatocellular (1)  ·  Cardiovascular Diseases (1)

Broader conditions

Digestive System Diseases (33)  ·  Pathologic Processes (33)  ·  Pathological Conditions, Signs and Symptoms (33)  ·  Fibrosis (30)  ·  Liver Diseases (30)  ·  Fatty Liver (9)  ·  Nutritional and Metabolic Diseases (5)  ·  Glucose Metabolism Disorders (4)  ·  Alcohol-Related Disorders (3)  ·  Chemically-Induced Disorders (3)  ·  Endocrine System Diseases (3)  ·  Hepatitis (3)  ·  Immune System Diseases (3)  ·  Metabolic Diseases (3)  ·  Nutrition Disorders (3)

Interventions

Ultrasonography (4)  ·  Elasticity Imaging Techniques (2)  ·  Atorvastatin (1)  ·  Ethanol (1)  ·  Hematologic Tests (1)  ·  Liver Function Tests (1)  ·  Magnetic Resonance Imaging (1)  ·  Polymorphism, Single Nucleotide (1)  ·  Ramipril (1)  ·  Zinc (1)  ·  Zinc Sulfate (1)  ·  aramchol (1)  ·  candesartan (1)  ·  entecavir (1)

Sponsors

Chang Gung Memorial Hospital (2)  ·  Chinese University of Hong Kong (2)  ·  Manchester University NHS Foundation Trust (2)  ·  Seoul National University Hospital (2)  ·  Azienda USL Reggio Emilia - IRCCS (1)  ·  Brigham and Women's Hospital (1)  ·  Catholic University of the Sacred Heart (1)  ·  Centre Hospitalier Universitaire, Amiens (1)  ·  Children's Hospital Medical Center, Cincinnati (1)  ·  Children's Mercy Hospital Kansas City (1)  ·  Fibronostics USA, Inc (1)  ·  Galmed Research and Development, Ltd. (1)  ·  I.M. Sechenov First Moscow State Medical University (1)  ·  Kaohsiung Medical University Chung-Ho Memorial Hospital (1)  ·  Odense University Hospital (1)

Countries

United States (12)  ·  Italy (4)  ·  Hong Kong (3)  ·  South Korea (3)  ·  Taiwan (3)  ·  France (2)  ·  Lithuania (2)  ·  United Kingdom (2)  ·  Chile (1)  ·  Denmark (1)  ·  Egypt (1)  ·  Georgia (1)  ·  Germany (1)  ·  Israel (1)  ·  Mexico (1)

Top investigators

Abeer El-Motwally, Msc (1)  ·  Aleksander Krag, MD, PhD (1)  ·  Algirdas E Tamosiunas, MD, PhD (1)  ·  Chia-Yen Dai (1)  ·  Ching-I Huang (1)  ·  Chung-Feng Huang (1)  ·  Claude B Sirlin, MD (1)  ·  Daniele Pastori, MD (1)  ·  David Diehl, MD (1)  ·  David N. Herndon, MD (1)  ·  Francesco Angelico, MD (1)  ·  Francesco Baratta, MD (1)  ·  Frank DiPaola, MD (1)  ·  Gamal Badra, Prof (1)

Results publications

PMID 11095334, PMID 21751301, PMID 22229701, PMID 24280876, PMID 25851300, PMID 26004669, PMID 26226095, PMID 26269292, PMID 31887443, PMID 32925554, PMID 34401690, PMID 34513946, PMID 34621052, PMID 34925649, PMID 35327522, PMID 35820779, PMID 37592403, PMID 38053913, PMID 39437136, PMID 39601324, PMID 40205145, PMID 41273899, PMID 41299502, PMID 9193771

NIH funding

U54CA193417 (1)